KCNN4 and cyst: Ex vivo exposure of metanephroi to a pharmacologic activator of KCa3.1 potentiated cyst initiation and progression, whereas exposure to pharmacologic inhibitors of KCa3.1 either prevented cyst enlargement or promoted complete cyst regression.